Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease

Journal of Infectious Diseases

Volumn 186, Issue SUPPL. 2, 2002, Pages

  Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

CELL SPECIFICITY; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TAXONOMY; VIRUS INFECTION; VIRUS LOAD;

CD8-POSITIVE T-LYMPHOCYTES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PARAPARESIS, TROPICAL SPASTIC; RNA, MESSENGER; VIRAL LOAD;

EID: 0036891343     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344269     Document Type: Conference Paper

References (57)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
2. de The G, Bomford R. An HTLV-I vaccine: Why, how, for whom? AIDS Res Hum Retroviruses 1993; 9:381-6.
3. Gessain A. Epidemiology of HTLV-I and associated diseases. In: Hollsberg P, Hafler D, eds. Human T-Cell Lymphotropic Virus Type I. Chichester, UK: John Wiley and Sons, 1996:33-64.
4. Blattner WA, Gallo RC. Epidemiology of HTLV-I and HTLV-II infection. In: Takatsuki K, ed. Adult T-Cell Leukemia. Oxford, UK: Oxford University Press, 1994:45-90.
5. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10.
6. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet 1986; 1:1031-2.
7. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-80.
8. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I [letter]. Lancet 1989; 1:441.
9. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2:1184-7.
10. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy [letter]. Lancet 1987; 2:1220.
11. Vernant JC, Buisson G, Magdeleine J, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjogren syndrome [letter]. Lancet 1988; 1:177.
12. Levin MC, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): A chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 1997; 3:126-40.
13. Izumo S, Usuku K, Osame M, Machigashira K, Johnson M, Hakagawa M. The neuropathology of HTLV-I associated myelopathy in Japan: Report of an autopsy case and review of the literature. In: Roman GC, Vernant JC, Osame M, eds. HTLV-I and the Nervous System. New York: Alan R Liss, 1989:261-7.
14. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990; 96:103-23.
15. Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K. Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 1993; 56:1004-7.
16. Akizuki S, Yoshida S, Setoguchi M. The neuropathology of human T cell lymphotropic virus type I-associated myelopathy. In: Roman GC, Vernant JC, Osame M, eds. HTLV-I and the Nervous System. New York: Alan R Liss, 1989:253-60.
17. Wu E, Dickson DW, Jacobson S, Raine CS. Neuroaxonal dystrophy in HTLV-I-associated myelopathy/tropical spastic paraparesis: Neuropathologic and neuroimmunologic correlations. Acta Neuropathol 1993; 86:224-35.
18. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1993; 52:424-30.
19. Moore GR, Traugott U, Scheinberg LC, Raine CS. Tropical spastic paraparesis: A model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 1989; 26:523-30.
20. Levin MC, Lehky TJ, Flerlage AN, et al. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type 1-associated neurologic disease. N Engl J Med 1997; 336:839-45.
21. Umehara F, Nakamura A, Izumo S, et al. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 1994; 53:617-24.
22. Kira J, Itoyama Y, Koyanagi Y, et al. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1992; 31:39-45.
23. Ohara Y, Iwasaki Y, Izumo S, Kobayashi I, Yoshioka A. Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy. Arch Virol 1992; 124:31-43.
24. Lehky TJ, Fox CH, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37:167-75.
25. Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame M. Expression of adhesion molecules and monocyte chemoattractant protein-I (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 1996; 91:343-50.
26. Soldan S. Immune response to HTLV-I and HTLV-II. In: Walker GPB, ed. Retroviral Immunology: Immune Responses and Restoration. Totowa, NJ: Humana Press, 2001:159-90.
27. Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:223-6.
28. Tendler CL, Greenberg SJ, Burton JD, et al. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 1991; 46:302-11.
29. Kitajima I, Osame M, Izumo S, Igata A. Immunological studies of HTLV-I associated myelopathy. Autoimmunity 1988; 1:125-31.
30. Kramer A, Jacobson S, Reuben JF, et al. Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans [letter]. Lancet 1989; 2:923-4.
31. + T cells. Blood 2001; 98:1506-11.
32. Azimi N, Jacobson S, Leist T, Waldmann TA. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 1999; 163:4064-72.
33. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348:245-8.
34. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993; 177:1567-73.
35. - lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 1998; 161:482-8.
36. + cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with HTLV-I provirus load. J Infect Dis 2001; 183:197-205.
37. -) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99:88-94.
38. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188:628-36.
39. Koenig S, Woods RM, Brewah YA, et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol 1993; 151:3874-83.
40. Utz U, Koenig S, Coligan JE, Biddison WE. Presentation of three different viral peptides, HTLV-1 tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2. 1 molecule. J Immunol 1992; 149:214-21.
41. -) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/ TSP patients. Proc Natl Acad Sci USA 1998; 95:7568-73.
42. - T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 2001; 50:807-12.
43. Kubota R, Soldan SS, Martin R, Jacobson S. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/ TSP patient. J Neurovirol 2002; 8:53-7.
44. Kubota R, Fujiyoshi T, Izumo S, et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:147-54.
45. Nagai M, Usuku K, Matsumoto W. et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4:586-93.
46. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990; 64:5682-7.
47. +) T cells are an in vivo reservoir for human T-cell lymphotropic virus type 1. Blood 2001; 98:1858-61.
48. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95:1386-92.
49. +) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000; 13:657-64.
50. Gessain A, Saal F, Gout O, et al. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 1990; 75:428-33.
51. Furukawa Y, Osame M, Kubota R, Tara M, Yoshida M. Human T-cell leukemia virus type-1 (HTLV-I) tax is expressed at the same level in infected cells of HTLV-I-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995; 85:1865-70.
52. Moritoyo T, Izumo S, Moritoyo H, et al. Detection of human T-lymphotropic virus type I p40 Tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 1999; 5:241-8.
53. Jacobson S, McFarlin DE, Robinson S, et al. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol 1992; 32:651-7.
54. Elovaara I, Utz U, Smith S, Jacobson S. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease. J Neuroimmunol 1995; 63:47-53.
55. Lehky T, Cowan E, Lampson L, Jacobson S. Induction of HLA class I and class II expression in human T lymphotropic virus type-I infected neuroblastoma cells. J Virol 1994; 68:1854-63.
56. + cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Clin Invest 1994; 94:1830-9.
57. Bielekova B, Martin R. Multiple sclerosis; immunotherapy. Curr Treat Options Neurol 1999; 1:201-20.